Vistagen Therapeutics, Inc. (VTGN)
0.6619
-0.02
(-2.39%)
USD |
NASDAQ |
Dec 31, 16:00
0.6537
-0.01
(-1.24%)
After-Hours: 20:00
Vistagen Therapeutics Free Cash Flow: -53.96M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -82.95M |
| XOMA Royalty Corp. | -15.89M |
| Omeros Corp. | -105.32M |
| GeoVax Labs, Inc. | -24.29M |
| Daré Bioscience, Inc. | -17.15M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.76M |
| Cash from Investing (Quarterly) | -0.094M |
| Cash from Financing (Quarterly) | 27.65M |
| Free Cash Flow Per Share (Quarterly) | -0.3866 |
| Free Cash Flow to Equity (Quarterly) | -13.33M |
| Free Cash Flow to Firm (Quarterly) | -13.82M |
| Free Cash Flow Yield | -252.7% |